Argentina vs Japan: Reported rate of new cervical cancer cases
Argentina
10.64 per 100,000 women
in 2017
Japan
11.85 per 100,000 women
in 2015
Argentina rank
12th
Japan rank
10th
Reported rate of new cervical cancer cases over time
- Argentina
- Japan
How they compare
Japan currently reports 11.85 per 100,000 women against 10.64 per 100,000 women in Argentina, a difference of 1.21 per 100,000 women.
That makes Japan's figure about 1.1 times Argentina's.
The two have swapped places 1 time across 13 shared years of data; in 2003 it was Argentina ahead.
Argentina ranks 12th and Japan ranks 10th of 46 countries.
Argentina has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Argentina | Japan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 13.9 per 100,000 women | 8.15 per 100,000 women | 5.75 per 100,000 women | Argentina |
| 2010s | 13.12 per 100,000 women | 11.03 per 100,000 women | 2.09 per 100,000 women | Argentina |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher reported rate of new cervical cancer cases, Argentina or Japan?
- Japan, at 11.85 per 100,000 women against 10.64 per 100,000 women in Argentina as of 2015.
- What is the difference in reported rate of new cervical cancer cases between Argentina and Japan?
- 1.21 per 100,000 women, with Japan ahead.
- How many years of comparable data are there for Argentina and Japan?
- 13 years are reported by both, from 2003 to 2015.
- How do Argentina and Japan rank globally for reported rate of new cervical cancer cases?
- Argentina ranks 12th and Japan ranks 10th of 46 countries.
- Where does this data come from?
- Global Cancer Observatory (2025) – processed by Our World in Data, published as Reported rate of new cervical cancer cases. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported number of new cervical cancer cases per 100,000 women, based on data from cancer registries. Comparisons may be affected by differences in measurement, including screening and diagnosis.